Drug Safety Update
January 2021: SSRI/SNRI antidepressant medicines: small increased risk of postpartum haemorrhage when used in the month before delivery
December 2011: Citalopram and escitalopram QT interval prolongation new maximum daily dose recommendations.
March 2010: Fluoxetine: possible small risk of congenital cardiac defects
Kent and Medway NHS and Social Care Partnership (KMPT) Formulary has detailed information for the treatment of depression follow the link below (this includes information for primary care prescribers)
Depression
Guidelines on the the diagnosis and treatment of depression have been published this includes advice on the choice of antidepressant
SSRIs may increase the risk of bleeding- the risk is similar to that associated with NSAIDs. Take care in patients receiving concurrent antiplatelet drugs, anticoagulants, NSAIDs or other drugs which increase bleeding risk.
